Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled study

Source: Annals of Oncology, doi:10.1093/annonc/mdp541 Author: R. Rauck et al. Background: Fentanyl buccal soluble film (FBSF) has been developed as a treatment of breakthrough pain in opioid-tolerant patients with cancer. The objective of this study was to evaluate the efficacy of FBSF at doses of 200â€"1200 µg in the management of breakthrough pain in patients with cancer receiving [...]